Literature DB >> 9499191

Overexpression of c-erbB-3 in various stages of human squamous cell carcinomas.

T Funayama1, T Nakanishi, K Takahashi, S Taniguchi, M Takigawa, T Matsumura.   

Abstract

Amplification of the c-erbB-3 gene and the expression of its mRNA and protein in human squamous cell carcinomas (SCC) were analyzed. Although no amplification of the c-erbB-3 gene was observed, overexpression of its mRNA was observed in SCC by RT-PCR. The expression of this gene in SCC was 15-50 times higher than in normal fibroblasts. Overexpression of the secreted type of erbB-3 mRNA was also observed in all SCC. Moreover, overproduction of the c-erbB-3 protein was also detected in SCC by dot blot analysis using anti-c-erbB-3 monoclonal antibodies. In nude mice, the expression of c-erbB-3 mRNA was higher in metastatic tumors compared with primary tumors. These results suggest that both the transmembrane and secreted types of c-erbB-3 play a significant role in the formation and development of SCC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9499191     DOI: 10.1159/000011851

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  9 in total

1.  Inhibition of ErbB3 by a monoclonal antibody that locks the extracellular domain in an inactive configuration.

Authors:  Sangwon Lee; Etienne B Greenlee; Joseph R Amick; Gwenda F Ligon; Jay S Lillquist; Edward J Natoli; Yaron Hadari; Diego Alvarado; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-12       Impact factor: 11.205

2.  ErbB3 upregulation by the HNSCC 3D microenvironment modulates cell survival and growth.

Authors:  J O Humtsoe; E Pham; R J Louie; D A Chan; R H Kramer
Journal:  Oncogene       Date:  2015-06-15       Impact factor: 9.867

3.  Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands.

Authors:  P O-charoenrat; P Rhys-Evans; W J Court; G M Box; S A Eccles
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

Review 4.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

5.  Enhancement of erbB2 and erbB3 expression during oral oncogenesis in diabetic rats.

Authors:  Eleftherios Vairaktaris; Lambros Goutzanis; Stavros Vassiliou; Sofia Spyridonidou; Emeka Nkenke; Georgios Papageorgiou; Pashalis Strantzias; Andreas Lazaris; Christos Yapijakis; Efstratios Patsouris
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-18       Impact factor: 4.553

6.  Expression, purification, crystallization and preliminary X-ray analysis of the HER3-9E12 Fab complex.

Authors:  Kecheng He; Ang Huang; Yong Huang; Hiroaki Takeda
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-05-24       Impact factor: 1.056

7.  ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1).

Authors:  Dane A Hayes; Dale A Kunde; Robyn L Taylor; Stephen B Pyecroft; Sukhwinder Singh Sohal; Elizabeth T Snow
Journal:  PLoS One       Date:  2017-06-07       Impact factor: 3.240

8.  Ligand-Independent EGFR Activation by Anchorage-Stimulated Src Promotes Cancer Cell Proliferation and Cetuximab Resistance via ErbB3 Phosphorylation.

Authors:  Masami Nozaki; Hiroki Yasui; Yuichi Ohnishi
Journal:  Cancers (Basel)       Date:  2019-10-14       Impact factor: 6.639

9.  Advances in Targeting HER3 as an Anticancer Therapy.

Authors:  Ning Jiang; Nabil F Saba; Zhuo Georgia Chen
Journal:  Chemother Res Pract       Date:  2012-11-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.